The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B.

Across all follow-up time points, the CHB group consistently exhibited higher rates of HBeAg seroclearance and seroconversion than the CHB-MASLD group, although the differences did not reach statistical significance ( Figures 3H, I ). 3.5 Factors associated with HBsAg seroclearance LASSO regression was used to identify factors associated with HBsAg seroclearance.

also in 111,027 other papers